Xiaoyang li

Xiaoyang Li is a Principal at Vivo Capital based in Palo Alto, California. In her current role, she evaluates and executes healthcare investments, focusing on development-stage and commercial-stage therapeutics in the United States alongside revenue-stage companies in Greater China. Prior to her promotion to Principal, she served as an analyst supporting the deployment of Vivo Capital's ninth investment fund. Her academic credentials include a doctorate in Chemistry from Stanford University and a Master of Science in Business Analytics with a finance concentration from Duke University. Additionally, she holds a Bachelor of Engineering with First Class Honors in Materials Sciences from Imperial College London and a Bachelor of Arts in Economics from New York University. Li leverages her multidisciplinary research background in medical sciences, nanotechnology, and chemistry to guide cross-border healthcare investment strategies.